| References |
|
|
Alberman E
(2002)
The National Down Syndrome Cytogenetic Register (NDSCR).
Journal of Medical Screening
9(3): 97–98.
|
|
|
Al-Jader LN,
Goodchild MC,
Ryley HC and
Harper PS
(1990)
Attitudes of parents of CF children towards neonatal screening and antenatal diagnosis.
Journal of Clinical Genetics
38: 460–465.
|
|
|
Al-Jader LN and
Hopkins S
(2000)
Development of an antenatal screening programme for congenital abnormalities in a South Wales district; lessons learnt for clinical governance.
Community Genetics
3: 31–37.
|
|
|
Al-Jader LN, and
Parry-Langdon N and
Smith RJW
(2000)
Survey of attitudes of pregnant women towards Down's syndrome screening.
Prenatal Diagnosis
20: 23–29.
|
|
|
Beazoglou T,
Heffley D,
Kyriopoulos J,
Vintzileos A and
Benn P
(1998)
Economic evaluation of prenatal screening for Down's syndrome in the USA.
Prenatal Diagnosis
18(12): 1241–1252.
|
|
|
Czeizel AE
(1995)
Nutritional supplementation and prevention of congenital abnormalities.
Current Opinion in Obstetrics and Gynaecology
7(2): 88–94.
|
|
|
Glazier R,
Goel V,
Holzapfel S, et al.
(1997)
Written patient information about triple-marker screening: a randomized, controlled trial.
Obstetrics & Gynaecology
90(5): 769–774.
|
|
|
Graham W,
Smith P,
Kamal A, et al.
(2000)
Randomised controlled trial comparing effectiveness of touch screen system with leaflet for providing women with information on prenatal tests.
British Medical Journal
320(7228): 155–160.
|
|
|
Hewison J,
Cuckle H,
Baillie C, et al.
(2001)
Use of videotapes for viewing at home to inform choice in Down's syndrome screening: a randomised controlled trial.
Prenatal Diagnosis
21(2): 146–149.
|
|
|
Jepson RG,
Forbes CA,
Sowden AJ and
Lewis RA
(2001)
Increasing informed uptake and non-uptake of screening: evidence from systematic review.
Health Expectations
4(2): 116–130.
|
|
|
Murray J,
Cuckle H,
Taylor G,
Littlewood J and
Hewison J
(1999)
Screening for cystic fibrosis.
Health Technology Assessment
3: 8.
|
|
|
Mutton D,
Ide RG and
Alberman E
(1998)
Trends in prenatal screening for and diagnosis of Down's syndrome: England and Wales, 1989–97.
British Medical Journal
317: 922–923.
|
|
|
Shackley P and
Cairns J
(1996)
Evaluating the benefits of antenatal screening: an alternative approach.
Health Policy
36(2): 103–115.
|
|
|
Stone DH and
Stewart S
(1996)
Screening and the new genetics; a public health perspective on the ethical debate.
Journal of Public Health Medicine
18(1): 3–5.
|
|
|
Wald JW,
Kennard A,
Hackshaw A and
McGuire A
(1998)
Antenatal screening for Down's syndrome.
Health Technology Assessment
2(1): 99.
|
| Further Reading |
|
|
book
Acheson D
(1988)
Public Health in England – The Report of the Committee of Enquiry into the Future Development of the Public Health Function, Cmd 289.
London: Her Majesty's Stationary Office.
|
|
|
book
Al-Jader LN
(1996)
Antenatal Screening for Down Syndrome, part II
London, UK: Faculty of Public Health Medicine of the Royal Colleges of Physicians.
|
|
|
book
Chapple J
(1994)
Screening Issues – The Public Health Aspect. Prenatal Diagnosis, the Human Side.
Abramsky L and
Chapple J (eds.)
London, UK: Chapman & Hall.
|
|
|
Chilaka VN,
Konje JC,
Stewart CR,
Narayan H and
Taylor DJ
(2001)
Knowledge of Down's syndrome in pregnant women from different ethnic groups.
Prenatal Diagnosis
21(3): 159–164.
|
|
|
Cochrane AL and
Holland WW
(1971)
Validation of screening procedures.
British Medical Bulletin
27: 3.
|
|
|
Crang-Svalenius E,
Dykes AK and
Jorgensen C
(1998)
Factors influencing informed choice of prenatal diagnosis: women's feelings and attitudes.
Fetal Diagnosis
13(1): 53–61.
|
|
|
Ford C,
Moore AJ,
Jordan PA, et al.
(1999)
The value of screening for Down's syndrome in a socioeconomically deprived area with high ethnic population.
British Journal of Obstetrics & Gynaecology
105(8): 855–859.
|
|
|
Gilbert RE,
Augood C,
Gupta R, et al.
(2001)
Screening for Down's syndrome: effects, safety, and cost effectiveness of first and second trimester strategies.
British Medical Journal
323: 423.
|
|
|
book
Gray JAM
(1996)
Dimensions and Definitions of Screening.
Milton Keynes, UK: NHS Executive Anglia and Oxford, Research and Development Directorate.
|
|
|
book
Holland WW and
Stewart S
(1990)
Screening in Healthcare: Benefit or Loss. The Nuffield Provincial Hospitals Trust, UK.
|
|
|
Howe D
(2001)
Modeling does not reflect reality.
British Medical Journal
323 (7310): 423.
|
|
|
Jorgensen FS
(1996)
Attitude of pregnant women to prenatal screening.
Ugeskrift for Laeger
158(39): 5447–5452.
|
|
|
Raffle AE
(2001)
Information about screening – is it to achieve high uptake or to ensure informed choice?
Health in Expectancy
4(2): 92–98.
|
|
|
Reynolds TM
(2000)
Down's syndrome screening: a controversial test, with more controversy to come!
Journal of Clinical Pathology
53(12): 893–898.
|
|
|
Sackett DL and
Holland WW
(1975)
Controversy in the detection of disease.
Lancet
2: 357–359.
|
|
|
Searle J
(1997)
Routine antenatal screening: not a case of informed choice.
Australian and New Zealand Journal of Public Health
21(3): 268–274.
|
|
|
Stemerding D and
van Berkel D
(2001)
Maternal serum screening, political decision-making and social learning.
Health Policy
56(2): 111–125.
|
|
|
book
Wald NJ (ed.)
(1984)
Antenatal and Neonatal Screening.
Oxford, UK: Oxford University Press.
|
|
|
book
Wilson JMG and
Jungner G
(1968)
Principles and Practice of Screening for Disease, Public Health Paper No. 34.
Geneva: WHO.
|
| Web Links |
|
|
ePath
The National Screening Committee Library. This is a library of literature published by the UK National Screening Committee of the Department of Health. It advises ministers on matters related to screening programmes
http://www.doh.gov.uk/nsc/library/lib_ind.htm
|
|
|
ePath
Public Health Genetics Unit. The UK National Health Service funds the Public Health Genetics Unit. Its Web site provides news and information about advances in genetics and their impact on public health and the prevention of disease http://www.medinfo.cam.ac.uk/phgu
|
